Interactions between respiratory syncytial virus and the host cell: Opportunities for antivirus strategies?

Expert Reviews in Molecular Medicine

Volumn 8, Issue 21, 2006, Pages 1-17

  Sugrue, Richard J ^a,b  

^a INSTITUTE OF VIROLOGY   (United Kingdom)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; ANTIVIRUS AGENT; BMS 433771; CYTOSKELETON PROTEIN; F ACTIN; G ACTIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMBRANE PROTEIN; MEVINOLIN; PALIVIZUMAB; PEPTIDE INHIBITOR; PROTEIN INHIBITOR; RESPIRATORY SYNCYTIAL VIRUS POLYMERASE INHIBITOR; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN; RIBONUCLEOPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ADHESION; CLINICAL TRIAL; CYTOSKELETON; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GENETIC CODE; HUMAN; INFECTION RISK; LIPID RAFT; MEMBRANE FUSION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRAL RESPIRATORY TRACT INFECTION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

HOST-PARASITE RELATIONS; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS REPLICATION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 33748340476     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399406000081     Document Type: Article

References (95)

1. Chanock, R.M., Roizman, B. and Myers, R. (1957) Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent. I. Isolation, properties and characterization. Am J Hyg 66, 281-290
2. Simoes, E.A. (1999) Respiratory syncytial virus infection. Lancet 354, 847-852
3. Openshaw, P.J. and Tregoning, J.S. (2005) Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 18, 541-555
4. Collins, P.L., Huang, Y.T. and Wertz, G.W. (1984) Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes. J Virol 49, 572-578
5. Collins, P.L., Hill, M.G. and Johnson, P.R. (1990) The two open reading frames of the 22 K mRNA of human respiratory syncytial virus: Sequence comparison of antigenic subgroups A and B and expression in vitro. J Gen Virol 71, 3015-3020
6. Fearns, R. and Collins, P.L. (1999) Model for polymerase access to the overlapped L gene of respiratory syncytial virus. J Virol 73, 388-397
7. Collins, P.L. (1991) The molecular biology of human respiratory syncytial virus (RSV) of the genus Pneumovirus. In The Paramyxoviruses (Kingsbury, D.W., ed.), 108-162, Plenum Press
8. Yu, Q., Hardy, R.W. and Wertz, G.W. (1995) Functional cDNA clones of the human respiratory syncytial (RS) virus N, P and L proteins support replication of RS virus genomic RNA analogs and define minimal transacting requirements for RNA replication. J Virol 69, 2412-2419
9. Mazumder, B. and Barik, S. (1994) Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: Transdominant negative phenotype of phosphorylation-defective P mutants. Virology 205, 104-111
10. Collins, P.L. et al. (1996) Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc Natl Acad Sci U S A 93, 81-85
11. Hardy, R.W. and Wertz, G.W. (1998) The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J Virol 72, 520-526
12. Fearns, R. and Collins, P.L. (1999) Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol 73, 5852-5864
13. Bermingham, A. and Collins, P.L. (1999) The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci U S A 96, 11259-11264
14. Rodriguez, L. et al. (2004) Human respiratory syncytial virus matrix protein is an RNA-binding protein: Binding properties, location and identity of the RNA contact residues. J Gen Virol 85, 709-719
15. Ghildyal, R. et al. (2002) Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol 83, 753-757
16. Sugrue, R.J. et al. (2001) Furin cleavage of the respiratory syncytial virus fusion protein is not a requirement for its transport to the surface of virus-infected cells. J Gen Virol 82, 1375-1386
17. Zimmer, G., Budz, L. and Herrler, G. (2001) Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences. J Biol Chem 276, 31642-31650
18. Gonzalez-Reyes, L. et al. (2001) Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A 98, 9859-9864
19. Scheid, A. and Choppin, P.W. (1977) Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology 80, 54-66
20. Collins, P.L., Huang, Y.T. and Wertz, G.W (1984) Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc Natl Acad Sci U S A 81, 7683-7687
21. Zimmer, G., Trotz, I. and Herrler, G. (2001) N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. J Virol 75, 4744-4751
22. Lambert, D.M. (1988) Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology 164, 458-466
23. McDonald, T.P. et al. (2006) Evidence that maturation of the N-linked glycans of the respiratory syncytial virus (RSV) glycoproteins is required for virus-mediated cell fusion: The effect of alpha-mannosidase inhibitors on RSV infectivity. Virology 350, 289-301
24. Zimmer, G. et al. (2003) Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus. J Biol Chem 278, 46854-46861
25. Collins, P.L. and Mottet, G. (1992) Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: Altered O-glycosylation in the presence of brefeldin A. J Gen Virol 73, 849-863
26. Langedijk, J.P. et al. (1998) Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor. Virology 243, 293-302
27. Levine, S., Klaiber-Franco, R. and Paradiso, P.R. (1987) Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 68, 2521-2524
28. Karron, R.A. et al. (1997) Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci U S A 94, 13961-13966
29. Teng, M.N., Whitehead, S.S. and Collins, P.L. (2001) Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289, 283-296
30. Techaarpornkul, S., Barretto, N. and Peeples, M.E. (2001) Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J Virol 75, 6825-6834
31. Hendricks, D.A., McIntosh, K. and Patterson, J.L. (1988) Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol 62, 2228-2233
32. Rixon, H.W. et al. (2005) The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen-activated protein kinase p38-dependent tyrosine kinase activity during virus infection. J Gen Virol 86, 375-384
33. Olmsted, R.A. and Collins, P.L. (1989) The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J Virol 63, 2019-2029
34. Anderson, K. et al. (1992) Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: A conserved feature among human and bovine respiratory syncytial viruses. Virology 191, 417-430
35. Feldman, S.A. et al. (2001) Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex. Arch Virol 146, 2369-2383
36. Bukreyev, A. et al. (1997) Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J Virol 71, 8973-8982
37. Atreya, P.L, Peeples, M.E. and Collins, P.L. (1998) The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J Virol 72, 1452-1461
38. Bossert, B. and Conzelmann, K.K. (2002) Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: A chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J Virol 76, 4287-4293
39. Spann, K.M. et al. (2004) Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78, 4363-4369
40. Lo, M.S., Brazas, R.M. and Holtzman, M.J. (2005) Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79, 9315-9319
41. Ramaswamy, M. et al. (2006) Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344, 328-339
42. Krusa, T. and Streckert, H.J. (1997) Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch Virol 142, 1247-1254
43. Hallak, L.K. et al. (2000) Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271, 264-275
44. Karger, A., Schmidt, U. and Buchholz, U.J. (2001) Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin. J Gen Virol 82, 631-640
45. Tripp, R.A. et al. (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2, 732-738
46. Harcourt, J.L, Karron, R.A. and Tripp, R.A. (2004) Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis. J Infect Dis 190, 1936-1940
47. Harcourt, J. et al. (2006) Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1 + T cell responses. J Immunol 176, 1600-1608
48. Gower, T.L. et al. (2005) RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology. J Virol 79, 5326-5336
49. Pastey, M.K. et al. (2000) A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat Med 6, 35-40
50. Budge, P.J. et al. (2004) RhoA-derived peptide dimers share mechanistic properties with other palyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G. J Virol 78, 5015-5022
51. Budge, P.J. and Graham, B.S. (2004) Inhibition of respiratory syncytial virus by RhoA-derived peptides: Implications for the development of improved antiviral agents targeting heparin-binding viruses. J Antimicrob Chemother 54, 299-302
52. Werling, D. et al. (1999) Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J Leukoc Biol 66, 50-58
53. Brown, G. et al. (2002) Caveolin-1 is incorporated into mature RSV particles during virus assembly on the surface of virus-infected cells. J Gen Virol 83, 611-621
54. Lamb, R.A. (1993) Paramyxovirus fusion: A hypothesis for changes. Virology 197, 1-11
55. Colman, P.M. and Lawrence, M.C. (2003) The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol 4, 309-319
56. Ruiz-Arguello, M.B. et al. (2004) Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism. J Gen Virol 85, 3677-3687
57. Chambers, P., Pringle, C.R. and Easton, A.J. (1990) Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol 71, 3075-3080
58. Barik, S. (1992) Transcription of human respiratory syncytial virus genome RNA in vitro: Requirement of cellular factor(s). J Virol 68, 6813-6818
59. Burke, E. et al. (1998) Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology 252, 137-148
60. Moyer, S.A., Baker, S.C. and Lessard, J.L. (1986) Tubulin: A factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci U S A 83, 5405-5409
61. McDonald, T.P. et al. (2004) Evidence that the respiratory syncytial virus polymerase complex associates with lipid rafts in virus-infected cells: A proteomic analysis. Virology 330, 147-157
62. Mason, S.W. et al. (2004) Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor. Nucleic Acids Res 32, 4758-4767
63. Brasier, A.R. et al. (2004) Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J Virol 78, 11461-11476
64. Brown, G. et al. (2005) Evidence for an association between heat shock protein 70 and the respiratory syncytial virus polymerase complex within lipid-raft membranes during virus infection. Virology 338, 69-80
65. Qanungo, K.R. et al. (2004) Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA. Proc Natl Acad Sci U S A 101, 5952-5957
66. Brown, G. et al. (2002) Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J Gen Virol 83, 1841-1850
67. McCurdy, L.H. and Graham, B.S. (2003) Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation. J Virol 77, 1747-1756
68. Brown, G. et al. (2004) Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology 327, 175-185
69. Li, M. et al. (2002) Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression. J Virol 76, 11845-11852
70. Arumugham, R.G. et al. (1989) Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virus. J Biol Chem 264, 10339-10342
71. Henderson, G., Murray, J. and Yeo, R.P. (2002) Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins. Virology 300, 244-254
72. Jeffree, C.E. et al. (2003) Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy. Virology 306, 254-267
73. Marschang, P. et al. (1995) Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur J Immunol 25, 285-290
74. Saifuddin, M. et al. (1997) Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol 78, 1907-1911
75. Rawat, S.S. et al. (2003) Modulation of entry of enveloped viruses by cholesterol and sphingolipids. Mol Membr Biol 20, 243-254
76. Salaun, C., James, D.J. and Chamberlain, L.H. (2004) Lipid rafts and the regulation of exocytosis. Traffic 5, 255-264
77. Kallewaard, N.L., Bowen, A.L. and Crowe, J.E., Jr. (2005) Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology 331, 73-81
78. Burke, E. et al. (2000) Profilm is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J Virol 74, 669-675
79. Bitko, V. et al. (2003) Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus. BMC Microbiol 3,9
80. Lambert, D.M. et al. (1996) Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci U S A 93, 2186-2191
81. Kilby, J.M. et al. (1998) Potent suppression of HIV-1 replication in humans by T-(20), a peptide inhibitor of gp41-mediated virus entry. Nat Med 4, 1302-1307
82. Huntley, C.C. et al. (2002) RFI-(641), a potent respiratory syncytial virus inhibitor. Antimicrob Agents Chemother 46, 841-847
83. Weiss, W.J. et al. (2003) Inhalation efficacy of RFI-641 in an African green monkey model of RSV infection. J Med Primatol 32, 82-88
84. Cianci, C., Meanwell, N. and Krystal, M. (2005) Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor. J Antimicrob Chemother 55, 289-292
85. Razinkov, V. et al. (2002) RSV entry inhibitors block F-protein mediated fusion with model membranes. Antiviral Res 55, 189-200
86. Cianci, C. et al. (2004) Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection. Antimicrob Agents Chemother 48, 2448-2454
87. Douglas, J.L. et al. (2003) Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein. J Virol 77, 5054-5064
88. Douglas, J.L. et al. (2005) Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms. Antimicrob Agents Chemother 49, 2460-2466
89. Liuzzi, M. et al. (2005) Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase. J Virol 79, 13105-13115
90. Mijatovic, T. et al. (2006) Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 8, 402-412
91. Frese, S. et al. (2003) Cell death induced by down-regulation of heat shock protein 70 in lung cancer cell lines is p53-independent and does not require DNA cleavage. J Thorac Cardiovasc Surg 126, 748-754
92. Gower, T.L. and Graham, B.S. (2001) Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrob Agents Chemother 45, 1231-1237
93. Bitko, V. et al. (2005) Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 11, 50-55
94. Zhang, W. et al. (2005) Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 11, 56-62
95. Peeples, M. and Levine, S. (1979) Respiratory syncytial virus polypeptides: Their location in the virion. Virology 95, 137-145